Healthy Skepticism Library
Items published in 2009
There are 1966 items in the Healthy Skepticism Library that were published in 2009.
Page 20 of 20 pages « First < 18 19 20
HSL16080
Limbu Y, Torres IM.
The effects of involvement and ad type on attitudes toward direct-to-consumer advertising of prescription drugs.
J Health Hum Serv Adm 2009 Sum; 32:(1):107-38
http://www.ncbi.nlm.nih.gov/pubmed/19558035
HSL16098
Rutherford BR, Sneed JR, Roose SP.
Does study design influence outcome? The effects of placebo control and treatment duration in antidepressant trials.
Psychother Psychosom 2009; 78:(3):172-81
http://content.karger.com/produktedb/produkte.asp?typ=fulltext&file=000209348
HSL16100
Kale SA, Barkin RL.
Resuscitation and rescue of the pharmaceutical detail: a prescriber-drug representative collaboration.
Compr Ther 2009 Sum; 35:(2):68-71
http://www.ncbi.nlm.nih.gov/pubmed/19618754
HSL16164
Martin JH, Beer C, Morris RG, Doogue MP.
Doctors and the pharmaceutical industry: time for a national policy?
MJA 2009; 191:(3):189-190
http://www.mja.com.au/public/issues/191_03_030809/letters_030809_fm-4.html
HSL16459
Gérvas J, Mansfield PR
Physicians, the industry and population health
Journal of Epidemiology and Community Health 2009; 63:(10):773-774
http://jech.bmj.com/cgi/content/extract/63/10/773
HSL16469
Van Der Weyden MB
Confronting conflict of interest
eMJA 2009; 191:(5):241
http://www.mja.com.au/public/issues/191_05_070909/martin_070909.html
HSL16529
Gülöksüz S, Oral ET, Ulaş H.
[Attitudes and behaviors of psychiatry residents and psychiatrists working in training institutes towards the relationship between the pharmaceutical industry and physicians].
Turk Psikiyatri Derg 2009; 20:(3):236-42
http://www.turkpsikiyatri.com/ftr.aspx?id=714
HSL16557
Tipton M, Bharadwaj S, Robertson D
Regulatory Exposure of Deceptive Marketing and its Impact on Firm Value
Journal of Marketing 2009;
http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1431978
HSL16669
Kalb PE, Greenberg PE.
Legal and economic perspectives concerning US government investigations of alleged off-label promotion by drug manufacturers.
Pharmacoeconomics 2009; 27:(8):623-5
http://www.ncbi.nlm.nih.gov/pubmed/19835018
HSL16758
Egilman D
Just say no
BMJ 2009; 339:b4527
http://www.bmj.com/cgi/content/short/339/nov02_2/b4527?rss=1
HSL16863
de Barros JA
Medicamentos: una contribución a la reflexión hacia su uso racional
RISAI 2009; 1:(3):1-5
http://pub.bsalut.net/cgi/viewcontent.cgi?article=1027&context=risai
HSL16887
Ghaemi SN
The failure to know what isn't known: negative publication bias with lamotrigine and a glimpse inside peer review
Evid Based Mental Health 2009; 12:(3):65
http://ebmh.bmj.com/content/12/3/65.full
HSL16933
Sweet MA, Simons MJ
As mass media evolves into 'masses of media', what are the implications for our health?
Med J Aust 2009; 191:(11/12):618-619
http://www.mja.com.au/public/issues/191_11_071209/swe11253_fm.html
HSL16934
Chapman S, Holding SJ, Ellerm J, Heenan RC, Fogarty AS, Imison M, Mackenzie R, McGeechan K
The content and structure of Australian television reportage on health and medicine, 2005-2009: parameters to guide health workers
Med J Aust 2009; 191:(11/12):620-624
http://www.mja.com.au/public/issues/191_11_071209/cha10706_fm.html
HSL16937
Archontaki M, Symvoulakis EK, Hajiioannou JK, Stamou AK, Kastrinakis S, Bizaki AJ, Kyrmizakis DE.
Increased frequency of rhinitis medicamentosa due to media advertising for nasal topical decongestants.
B-ENT 2009; 5:(3):159-62
http://www.ncbi.nlm.nih.gov/pubmed/19902852
HSL17018
Sismondo S, Nicholson SH.
Publication planning 101.
J Pharm Pharm Sci 2009; 12:(3):273-9
http://ejournals.library.ualberta.ca/index.php/JPPS/article/viewFile/6299/5594
HSL17053
Idris KM, Yousif MA, Mustafa AF
Influence of pharmaceutical industry's promotion on the doctors' prescribing patterns in Sudan
The Journal of Medicine Use in Developing Countries 2009; 1:(3):3- 13
www.usm.my/dsap/journal/article/disember2009/Article2.pdf
HSL17201
Ball JG, Liang A, Lee WN.
Representation of African Americans in direct-to-consumer pharmaceutical commercials: a content analysis with implications for health disparities.
Health Mark Q 2009; 26:(4):372-90
http://www.ncbi.nlm.nih.gov/pubmed/19916100
HSL17202
Fogel J, Novick D.
Direct-to-consumer advertisements of prescription medications over the Internet.
Health Mark Q 2009; 26:(4):347-71
http://www.ncbi.nlm.nih.gov/pubmed/19916099
HSL17203
Bhutada NS, Cook CL, Perri M 3rd.
Consumers responses to coupons in direct-to-consumer advertising of prescription drugs.
Health Mark Q 2009; 26:(4):333-46
http://www.ncbi.nlm.nih.gov/pubmed/19916098?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=2
HSL17204
DeLorme DE, Huh J, Reid LN.
Direct-to-consumer advertising skepticism and the use and perceived usefulness of prescription drug information sources.
Health Mark Q 2009; 26:(4):293-314
http://www.ncbi.nlm.nih.gov/pubmed/19916096
HSL17205
Silver LS, Stevens RE, Loudon D.
Direct-to-consumer advertising of pharmaceuticals: concepts, issues, and research.
Health Mark Q 2009; 26:(4):251-8
http://www.ncbi.nlm.nih.gov/pubmed/19916093
HSL17354
Smith BD
An exploratory study of key opinion leadership management trends among European pharmaceutical companies
Journal of Medical Marketing 2009; 9:(4):291–300
http://www.palgrave-journals.com/jmm/journal/v9/n4/abs/jmm200931a.html
HSL17357
Michael Stros, Juerg Hari, John Marriott
The relevance of marketing activities in the Swiss prescription drugs market: Two empirical qualitative studies
International Journal of Pharmaceutical and Healthcare Marketing 2009; 3:(4):323 - 346
http://www.emeraldinsight.com/Insight/viewContentItem.do?contentType=Article&contentId=1826906
HSL17849
Villanueva T
Centro Vasco de Información de Medicamentos CEVIME-MIEZ
Rev Port Clin Geral 2009; 25:724
http://www.osanet.euskadi.net/r8520361/es/ contenidos/informacion/presentacion_cevime/ es_1219/indice_c.html
HSL18178
Fava GA
The Decline of Pharmaceutical Psychiatry and the Increasing Role of Psychological Medicine
Psychother Psychosom 2009; 78:(4):220-227
http://content.karger.com/produktedb/produkte.asp?doi=214443
HSL14552
Global pharma market forecast to exceed $820bn in 2009
Manufacturing Chemist 2009
http://www.manufacturingchemist.com/story.asp?sectioncode=109&storycode=54583&c=1
HSL15999
Rimonabant: marketing authorization suspended... at last: withdrawal. Half-measures.
Prescrire Int 2009 Apr; 18:(100):16
http://www.ncbi.nlm.nih.gov/pubmed/19585720
HSL16224
Rowley J
Drugmakers’ Deal Doesn’t Bind Congress in Health-Care Debate
Bloomberg.com 2009 08 08
http://www.bloomberg.com/apps/news?pid=20601087&sid=aRJ2L450Pam8
HSL16240
Fauber J, Kissinger M
UW linked to ghostwriting
The Journal Sentinel 2009 Aug 15
http://www.jsonline.com/features/health/53315032.html
HSL16254
Taylor D
Branding Q&A
MedAdNews 2009
http://medad.canon-experts.com/expert/dale-taylor/
HSL16285
Wyeth Ghostwriting Archive
PLoS Med 2009;
http://www.plosmedicine.org/static/ghostwriting.action
HSL16353
Young T
Death by Prescription Toronto: Key Porter Books 2009
http://www.amazon.ca/Death-Prescription-Father-Daughters-Killer/dp/1552638251
HSL16381
Moynihan R
Drug Safety: Battle over popular bone drug Fosamax bursts into court
BMJ 2009 08 06;
http://www.bmj.com/cgi/content/extract/339/aug06_1/b3155
HSL16384
Exorcising authors
The Finanical Times 2009 08 30
http://www.ft.com/cms/s/0/f7434ad6-9588-11de-90e0-00144feabdc0.html?nclick_check=1
HSL16393
Bextra Whistleblower Case Started Investigation of Pfizer
Reuters 2009 09 02
http://www.reuters.com/article/pressRelease/idUS158792+02-Sep-2009+PRN20090902
HSL16420
Parsai G
Modify the pill advertisements, Drug Controller asks manufacturers
The Hindu 2009 09 09
http://beta.thehindu.com/news/national/article17177.ece
HSL16454
Williams SJ, Gabe J, Davis P
Pharmaceuticals and Society: Critical Discourses and Debates : Wiley-Blackwell 2009
http://au.wiley.com/WileyCDA/WileyTitle/productCd-1405190841,descCd-description.html
HSL16457
Hutton D
Whistleblowing at Health Canada: Chopra speaks out
CMAJ 2009 09 15; 181:(6-7):
http://www.cmaj.ca/cgi/content/full/181/6-7/E121
HSL16472
PharmaTimes Great Oxford Debate - 2009
Pharma Times 2009
http://www.pharmatimes.com/Competitions/Great-Oxford-Debate/2009debate.aspx
HSL16546
Sawaya L
The Persuasion Report Orleans, Canada: Reticulum 2009
https://cp.experthost.com/ssl/18/reticulum.ca/books_s3.php
HSL16587
Issues and Challenges Related to Local Television: Report of the Standing Committee on Canadian Heritage
: House of Commons, Canada 2009 Jun
http://www2.parl.gc.ca/HousePublications/Publication.aspx?DocId=4005108&Language=E&Mode=1&Parl=40&Ses=2
HSL16601
Evaluating evolving sales models & advanced technology for a customer centric approach
Pharmaceutical Sales Force Effectiveness Strategies 2009 Aug
http://www.reportlinker.com/p0148147/Pharmaceutical-Sales-Force-Effectiveness-Strategies-Evaluating-evolving-sales-models--advanced-technology-for-a-customer-centric-approach.html
HSL16656
Anvisa não pode regulamentar publicidade, diz juiz
Consultor Jurídico 2009 10 23
http://www.conjur.com.br/2009-out-23/anvisa-nao-competencia-regulamentar-publicidade-juiz
HSL16678
Perrone M
GAO: FDA fails to follow up on unproven drugs
Yahoo News 2009 10 26
http://news.yahoo.com/s/ap/20091026/ap_on_he_me/us_fda_unproven_drugs
HSL16679
FDA Needs to Enhance Its Oversight of Drugs Approved on the Basis of Surrogate Endpoints
United States Government Accountability Office 2009 Sep
http://www.gao.gov/new.items/d09866.pdf
HSL16760
Mayor S
Report calls for public education on screening to ensure more realistic expectations
BMJ 2009 11 03; 339:
http://www.bmj.com/cgi/content/short/339/nov03_1/b4533?rss=1
HSL16763
Carmichael M
Bitter Pills
Boston Magazine 2009 Nov
http://www.bostonmagazine.com/articles/bitter_pills/page1
HSL16769
Zinner DE, Bjankovic D, Clarridge B, Blumenthal D, Campbell EG
Participation Of Academic Scientists In Relationships With Industry
Health Affairs 2009; 28:(6):1814
http://content.healthaffairs.org/cgi/content/abstract/28/6/1814
HSL16796
Charlton BG
Are you an honest scientist? Truthfulness in science should be an iron law, not a vague aspiration.
Med Hypotheses 2009 Nov; 73:(5):633-5
http://linkinghub.elsevier.com/retrieve/pii/S0306-9877(09)00342-9
HSL16809
Brownlee S, Lenzer J
Does the Vaccine Matter?
The Atlantic 2009 Nov
http://www.theatlantic.com/doc/200911/brownlee-h1n1
HSL16820
The Differing Views Of Using Social Media In Pharma
Life Science Leader Magazine 2009 Dec
http://www.lifescienceleader.com/index.php?option=com_jambozine&layout=article&view=page&aid=3922
HSL16839
Verilogue Study: Does Higher DTC Spending Result in Positive Patient-Physician Conversations?
Verilogue 2009 11 09
http://www.verilogue.com/press_8.php
HSL16844
Conflicts of Interest in Clinical Trial Recruitment & Enrollment: A Call for Increased Oversight
The Center for Health & Pharmaceutical Law & Policy 2009 Nov
http://law.shu.edu/ProgramsCenters/HealthTechIP/upload/health_center_whitepaper_nov2009.pdf
HSL16856
Heisel W
Start naming names in the pharma ghostwriting scandal
Reporting on Health: Antidote: New Ways to Investigate Untold Health Stories 2009 Sep
http://www.reportingonhealth.org/blogs/start-naming-names-pharma-ghostwriting-scandal
HSL16872
Levinson DR
How Grantees Manage Financial Conflicts Of Interest In Research Funded By The National Institutes Of Health
Department of Health and Human Services 2009 Nov
http://oig.hhs.gov/oei/reports/oei-03-07-00700.pdf
HSL16898
Edwards J
AZ Promoted Seroquel as Superior to Haldol When Company Data Said It Wasn't
BNet 2009 11 04
http://industry.bnet.com/pharma/10005119/az-promoted-seroquel-as-superior-to-haldol-when-company-data-said-it-wasnt/
HSL16925
The Royal Australian and New Zealand College of Psychiatrists
Symposium on Commercial Sponsorship of Psychiatrist Education
2009
http://ranzcp.cmsaustralasia.com/video.load.php?videosource=rtmp://ocy932wr.rtmphost.com/09175/Panel_LR.FLV
HSL16935
Medicines Australia Code of Conduct: breaches
Aust Prescr 2009
http://www.australianprescriber.com/magazine/32/6/160/1/
HSL16996
Dunn A
Best Strategic Learning Investment in 2010?
Hoenig Carlson E Courtney Justice, The Cournell Group 2009 Dec
http://docs.google.com/fileview?id=0B2pN9F6nMK5MZjQ2MjEyYjMtNzc5Yi00NjVjLWIwZmItYTI1NDZlZTk2NDgw&hl=en
HSL17057
Iskowitz M
Pfizer nearly doubles amount spent on e-detailing
Medical Marketing & Media 2009 01 19
http://www.mmm-online.com/pfizer-nearly-doubles-amount-spent-on-e-detailing/article/161727/
HSL17144
Cassels A, van Wiltenburg J, Armstrong W
What’s in a Scan? How well are consumers informed about the benefits and harms related to screening technology (ct and pet scans) in Canada?
Canadian Centre for Policy Alternatives 2009 Mar
http://www.policyalternatives.ca/sites/default/files/uploads/publications/National_Office_Pubs/2009/Whats_in_a_Scan.pdf
HSL17400
Haag D
rapport in het kader van algemeen toezicht naar aanleiding van het onderzoek bij Sanofi Pasteur MSD naar het geneesmiddel Gardasil (Report about Sanofi)
Staatstoezicht Op De Volksgezondheid 2009 July
http://www.spmsd.nl/143608/Rapport-inspectie-nav-WOB-verzoek.pdf
HSL17401
Haag D
Rapport in het kader van algemeen toezicht naar annleiding van het onderzoek bij GSK naar geneesmiddel Cervarix
Staatstoezicht Op De Volksgezondheid 2009 July
http://www.gsk.nl/downloads/files/rapportonderoekbijGSKnaargeneesmiddelCervarix.pdf
HSL17660
Goldacre B
Bad Science : HarperCollins 2009
http://www.harpercollins.co.uk/Titles/36492/bad-science-ben-goldacre-9780007284870
HSL18166
Lush N
Millions of dollars wasted on reps
Pharma in Focus 2009 Mar
http://www.pharmainfocus.com.au/news.asp?newsid=2648
Page 20 of 20 pages « First < 18 19 20
